4,591 Shares in ICU Medical, Inc. (NASDAQ:ICUI) Acquired by Fox Run Management L.L.C.

Fox Run Management L.L.C. purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 4,591 shares of the medical instruments supplier's stock, valued at approximately $712,000.

Other hedge funds also recently made changes to their positions in the company. Harvest Fund Management Co. Ltd bought a new stake in ICU Medical in the fourth quarter valued at about $33,000. Point72 Hong Kong Ltd bought a new stake in shares of ICU Medical in the 3rd quarter valued at approximately $72,000. Venturi Wealth Management LLC raised its holdings in shares of ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after buying an additional 206 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in shares of ICU Medical by 166.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock worth $140,000 after buying an additional 567 shares during the period. Finally, Coldstream Capital Management Inc. acquired a new stake in ICU Medical in the 3rd quarter valued at $227,000. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Price Performance

Shares of ICU Medical stock traded down $4.12 during trading on Friday, reaching $140.16. The company's stock had a trading volume of 224,230 shares, compared to its average volume of 262,064. The stock has a 50-day moving average price of $154.42 and a two-hundred day moving average price of $163.84. The stock has a market capitalization of $3.44 billion, a P/E ratio of -30.67 and a beta of 0.73. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a one year low of $93.36 and a one year high of $196.26.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms have issued reports on ICUI. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective for the company in a research note on Wednesday, December 11th. StockNews.com cut shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Finally, Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $168.67.

Insider Transactions at ICU Medical

In other news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 6.70% of the stock is currently owned by corporate insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.